A 22 year old lady was referred to our joint ophthalmology clinic with bilateral proptosis following a routine visit to the opticians. She had a two year history of thyrotoxic symptoms which included sweats, palpitations, weight loss and anxiety, particularly pronounced in the 4 months prior to her presentation . Her past medical history included alopecia totalis and there was no family history of thyroid disease or autoimmunity.
On examination she had clear signs of thyrotoxicosis and was clinically in atrial fibrillation (AF) with a central heart rate of 195 beats/mins. Neck palpation revealed a moderate-sized smooth and symmetrical goitre with no bruits or lymphadenopathy. There was evidence of active thyroid eye disease with conjunctival injection, periorbital oedema and bilateral proptosis. Her investigations revealed severe thyrotoxicosis with a Free T4 109.8 pmol/l, Total T3>12.3 nmol/L and TSH< 0.05 miu/L. Her TSH-R antibodies were positive at 100u/L, consistent with a diagnosis of Graves' disease, and her electrocardiogram confirmed AF.
She was commenced on Carbimazole 20mg three time daily and 40 mg/day of prednisolone was added for the management of thyroid eye disease. A cardiology opinion was sought for her AF and she was started on 5mg bisoprolol and warfarin using a loading dose of 10mg/d for two days then 5 mg on the third day. Her INR on the fourth day before warfarin ingestion was 18.7 but the patient did not exhibit any symptoms or signs of bleeding.
Warfarin was stopped and the dose was subsequently adjusted to achieve an INR of 2-3. She became euthyroid in 6 weeks and reverted spontaneously into sinus rhythm. This was confirmed by repeat ECG and a 24 hour tape which also ruled out paroxysmal arrhythmias. Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13
Introduction
• Thyrotoxic atrial fibrillation (AF) occurs in 10% to 35% of patients with thyrotoxicosis with high risk of embolisation 1,2,3 .
• In addition to AF, the high risk of embolic events may be related to the thrombotic environment created by thyrotoxicosis 4 .
• Therefore anticoagulation of thyrotoxic patients with atrial fibrillation is advised, this can be stopped after restoration of euthyroidism and reversion to sinus rhythm 5 .
